F Brehmer, H A Haenssle, G Daeschlein, R Ahmed, S Pfeiffer, A Görlitz, D Simon, M P Schön, D Wandke, S Emmert

We conducted the first clinical trial with the novel PlasmaDerm® VU-2010 device to assess safety and, as secondary endpoints, efficacy and applicability of 45 s/cm(2) cold atmospheric plasma as add-on therapy against chronic venous leg ulcers.